St. Petersburg, Floriday (PRWEB) March 13, 2014
Dr. Jeffrey Adler of Adler Footcare New York is presenting at the 7th Annual Graham International Implant Symposium, a two-day event that brings together foot and ankle specialists to present and attend lectures on the latest in foot and ankle topics. Dr. Adler will be speaking on the use of stem cells in the first MP (metacarpophalangeal) joint surgery.
Stem Cell Replacement Therapy offers an advanced treatment option for problems like plantar fasciitis, Osteoarthritis, Achilles tendonitis and torn soft tissue.
Stem Cell Replacement Therapy is proving to be much more effective and long lasting than traditional treatments.
In the past common foot problems have been treated by physical therapy or orthotic therapy, but the results have often been poor, leaving patients continuing to struggle with the foot pain.
Stem cells are used by many physicians to treat a broad variety of conditions because of their ability to either replicate themselves or change into the cell type that is needed to repair the tissue that has been damaged. The New York podiatrists at Adler Footcare introduce live birth stem cells into the affected area. When a patient comes in for stem cell therapy, the affected area is carefully measured so the stem cells can be delivered directly to the area that needs the treatment.
“Stem cell treatment helps patients heal much quicker and allows them to return to their normal activities much sooner,” Dr. Adler said. “Actual recovery time will depend on each individual patient’s general health and medical diagnosis, but in the end they will be able to live life without chronic foot pain.”
Treatments using stem cells have been used by physicians for over 100 years. Stem Cell Replacement Therapy™ is covered by commercial insurance and Medicare, and is approved and regulated by the FDA. The product is tested and screened by medical professionals to eliminate the potential of any communicable diseases.
Graham International Implant Institute
The Graham International Implant Institute (GIII) is a global-reaching organization dedicated to research, training, certification and support on implantology for foot physicians worldwide.
The GIII provides live seminars in cities throughout the world, as well as specialized online training programs, year-round. It’s committed to elevating the standard of care in the arena of Extra-Osseous TaloTarsal Stabilization (EOTTS) through education. In addition, the GIII continues to look for and represent other innovative, revolutionary products that help solve foot disorders at their root and don't just ameliorate the symptoms
To learn more about Stem Cell Replacement Therapy or to schedule a consultation with a New York podiatrist at Adler Footcare, call (212) 704-4310 or visit http://www.mynycpodiatrist.com.
About Adler Footcare New York
Dr. Jeffrey L. Adler, Medical/Surgical Director and owner of Adler Footcare New York has been practicing podiatric medicine since 1979 and has performed thousands of foot and ankle surgeries. Dr. Adler is board certified in Podiatric Surgery and Primary Podiatric Medicine by the American Board of Multiple Specialties in Podiatry. Dr. Adler is also a Professor of Minimally Invasive Foot Surgery for the Academy of Ambulatory Foot and Ankle Surgeons. As one of only several in the country who perform minimally invasive podiatric surgery, Dr. Adler’s patients enjoy significantly reduced recovery times.